Resonance Specialties Ltd-$
PURCHASE OF MANUFACTURING UNIT FROM KAYGEE LABORATORIES PVT LTD
M&A
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 04 Aug 2026, 12:15 PM IST · BSE ID: e1524c78-5846-4aaa-abe6-411f6ade5e3c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is buying a factory it previously used from a related company for Rs. 29.98 crores.
🤖 AI Summary
- Board approved the purchase of a manufacturing facility from Kaygee Laboratories Private Limited for Rs. 29.98 crores.
- The unit, located in Mandideep, Madhya Pradesh, includes leasehold land, buildings, plant, machinery, and employees.
- The transaction is on a slump sale basis and requires shareholder approval, with expected completion by November 30, 2026.
- Kaygee Laboratories Private Limited is a promoter group company and a related party in this transaction.
- The acquired unit previously supplied chemical intermediates and APIs to Resonance Specialties on a job work basis.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consideration payable for purchase
Rs. 29.98 crores
Leasehold land area
22,304 sq. mtrs.
Industrial buildings area
5,227 sq. mtrs.
🏢 How This Affects the Company
The direct acquisition of the manufacturing unit can integrate the supply of chemical intermediates and APIs, which were previously manufactured and supplied on a job work basis. This could enhance control over production and supply chain for specific end products.
The acquisition involves a cash outflow of Rs. 29.98 crores for the purchase of the manufacturing facility. This transaction is subject to shareholder approval and will impact the balance sheet with the addition of new assets.
Resonance Specialties will directly manage the acquired manufacturing unit, including its employees and operations, bringing in-house the production of specific chemical intermediates and APIs. The unit has recent WHO, Geneva approval.
The acquisition from a promoter group company, Kaygee Laboratories Private Limited, constitutes a related party transaction. The filing states this is done at an arm’s length basis based on an independent valuation certificate.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will be required to approve the purchase of the manufacturing facility from Kaygee Laboratories Private Limited.
👤
Who Is Affected
All shareholders will be affected by the requirement to vote on the transaction. The transaction involves a promoter group company, Kaygee Laboratories Private Limited, which holds equity in a company that in turn holds equity in Resonance Specialties Limited.
🔍
Management Signal
The decision to acquire a long-standing supplier unit signals management's intent to integrate critical production processes and enhance direct control over its supply chain.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Shareholder meeting for approval of the manufacturing unit purchase.
Completion of the acquisition on or before November 30, 2026.
Disclosure of Unaudited Financial Results for Q1 ended June 30, 2026.
MEDIUM RISK
The transaction involves a related party and requires shareholder approval, introducing execution and oversight considerations.
💡 Investor Takeaway
Resonance Specialties Board approved the purchase of a manufacturing unit for Rs. 29.98 crores from promoter group entity, Kaygee Laboratories Private Limited. This unit, with WHO approval, previously supplied key intermediates on a job-work basis, and the acquisition requires shareholder approval.
⚖️ Strengths & Concerns
✅ Positives
- Acquisition of a manufacturing unit that has been supplying essential chemical intermediates and APIs on an exclusive basis.
- The acquired manufacturing unit holds recent inspection and approval from WHO, Geneva, indicating compliance with international standards.
⚠️ Concerns
- The acquisition consideration of Rs. 29.98 crores represents a notable cash outflow, requiring shareholder approval for the transaction.
- The transaction involves a related party, Kaygee Laboratories Private Limited, a promoter group company, requiring due diligence in its execution.
❓ Frequently Asked Questions
What is the consideration for Resonance Specialties' manufacturing unit purchase?
Resonance Specialties Limited's Board approved the purchase of a manufacturing facility for a consideration of Rs. 29.98 crores on a slump sale basis.
Who is the seller of the manufacturing unit to Resonance Specialties?
The seller is M/s. Kaygee Laboratories Private Limited, which is identified as a promoter group company and a related party to Resonance Specialties Limited.
What is the expected completion date for the manufacturing unit purchase?
The expected date of completion for the purchase of the manufacturing unit is on or before November 30, 2026, or a mutually agreed upon date.
What is included in the manufacturing unit being purchased by Resonance Specialties?
The manufacturing unit includes leasehold land admeasuring about 22,304 sq. mtrs., industrial buildings of about 5,227 sq. mtrs., plant & machineries, licenses, permits, and employees.
Does the manufacturing unit have any notable approvals?
Yes, the manufacturing unit proposed to be acquired is recently inspected and approved by WHO, Geneva.
Questions based on this BSE filing only. For information purposes.